Kidney cancer Doctors Abroad — Page 2

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Professor Dr. Sefik Igdem specializes in radiation oncology, with advanced expertise in treating kidney cancer using cutting-edge technologies.

• Board-certified in radiation oncology with decades of experience
• Uses Truebeam Stx and Halcyons technologies for precise treatment
• Professor at Demiroğlu Bilim University, training future oncologists
• Focuses on conformal treatments to minimize side effects

Dr. Antonio Alcaraz has performed over 500 successful urological surgeries, many using minimally invasive techniques, at Teknon Medical Center.

• 38 years of experience in urology and kidney transplantation
• Specializes in laparoscopic and robotic-assisted procedures, including Da Vinci system
• Heads the Department of Urology and kidney transplantation
• Member of American Urological Confederation and European Urological Society

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Serkan Keskin achieved 1st place nationally in his Medical Oncology board exam. He works with advanced treatments like immunotherapy at Memorial Şişli Hospital.

• Over 25 years of experience treating complex cancers
• Uses advanced techniques including targeted therapy and chemotherapy
• Holds membership in leading global societies like ASCO and ESMO
• Recognized with the Best Poster Award at a National Cancer Congress
• Completed his oncology subspecialty training at Istanbul University Institute of Oncology

Dr. Solak brings specialized training from Hacettepe University Cancer Institute and extensive experience with diverse cancers, including kidney cases at Hisar Hospital Intercontinental.

• Specialized in oncology at Istanbul Sisli Etfal Training and Research Hospital
• Fellowship at The University of Texas MD Anderson Cancer Center
• Expertise in gastrointestinal and urologic cancers
• Practices evidence-based protocols from top-tier training

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 publications and international recognition.

• Member of European Society of Medical Oncology (ESMO)
• Trained in Melanoma and Kidney Cancer Clinic at Mount Vernon Cancer Center
• Published co-author in 'Handbook of Advanced Cancer Care Treatment'
• Professor at Haliç University, Istanbul

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Mehmet Dogu Canoglu is a radiation oncologist at Anadolu Medical Center in Istanbul. He specializes in precise tumor targeting using MR Linac and CyberKnife technologies. Dr. Canoglu trained at Kocaeli University. He previously served at Medipol Mega University Hospital. He treats various cancers, including complex brain, prostate, and lung tumors.

• Expert in Varian TrueBeam and Trilogy radiation delivery systems.
• Performs stereotaxic radiosurgery and targeted radiotherapy for sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.
• Treats patients at a clinic ranked among the world's top 10 for medical tourism.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Prof. Köstler, an internationally recognized oncologist, brings over 22 years of specialized experience to the Wiener Privatklinik.

• His expertise lies in breast cancer, gynecologic malignancies, and targeted cancer therapies.
• He is an Associate Professor at the Medical University of Vienna, focusing on translational cancer research.
• Prof. Köstler contributed to early clinical trials on personalized, targeted drug therapies.
• He leads in biomarker development and individualized systemic cancer treatment strategies.

Professor of Medical Oncology since 2016 – Dr. Saglam leads the Gastrointestinal Oncology unit at Florence Nightingale Hospital.

• Over 29 years of experience in medical oncology
• Specialized in gastrointestinal oncology since 2005
• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO and ASCO professional societies

Specializes in lung, esophageal, and gastric cancers at Valued Med Hub Hospitals, bringing focused expertise to kidney cancer cases.

• Medical oncology specialist with training at Ankara Oncology Hospital
• Experience in multiple oncology clinics across Turkey
• Published researcher with work accessible on Google Scholar

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Dr. Topcu specializes in a wide range of cancers, including kidney cancer, with training at top international centers like MD Anderson and Sunnybrook Odette.

• Medical oncology specialist with over 18 years of experience
• Trained at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center
• Works at Valued Med Hub Hospitals
• Specializes in multiple cancer types, including kidney cancer